ABSTRACT
INTRODUCTION
Monochorionic twin pregnancies are associated with several unique complications, including selective fetal growth restriction (sFGR), twin-twin transfusion syndrome (TTTS), twin reversed arterial perfusion sequence and twin anemia-polycythemia sequence 1, 2 . As a consequence, monochorionic twin pregnancies are at increased risk of adverse perinatal outcome compared with dichorionic gestations 3, 4 .
Inconsistencies in the definition of sFGR make the prevalence of this condition difficult to determine, however, sFGR is observed in approximately 10-15% of monochorionic twin pregnancies 5 . It is conventionally defined as a condition in which the estimated fetal weight (EFW) of one fetus is below the 10 th centile and the intertwin EFW discordance is greater than 25% 6 . The condition can be further classified into Types I, II and III according to end-diastolic flow (EDF) in the umbilical artery (UA) of the smaller fetus 7 . The EDF is positive in Type-I, absent or reversed (AREDF) in Type-II and intermittent AREDF in Type-III sFGR. Pregnancies complicated by sFGR Type I are typically associated with a favorable outcome 8 . However, a small proportion will progress to sFGR Type II or III, both of which are associated with significantly higher perinatal morbidity and mortality 9 . An additional complication of monochorionic twin pregnancy, which arises as a consequence of imbalanced placental blood flow, is TTTS. This affects approximately 10% of monochorionic pregnancies and is defined by a marked discordance in amniotic fluid volume, with the deepest vertical pocket (DVP) ≤ 2 cm in one sac and ≥ 8 cm before 20 weeks' gestation and > 10 cm after 20 weeks in the other sac 1, 10, 11 . The severity of TTTS is classified according to Quintero staging 11 and the established treatment of choice is endoscopic laser coagulation of the intertwin communicating placental vessels 12, 13 . In 2015, Van Winden et al. 14 concluded that sFGR, present in up to two-thirds of pregnancies complicated by TTTS, is a risk factor for decreased donor survival.
The main objective of this study was to determine factors implicated in the adverse perinatal outcome of monochorionic diamniotic twin pregnancies complicated by sFGR. A secondary objective was to investigate the impact of coexisting TTTS on perinatal outcome and to determine ultrasound parameters that are valuable predictors of fetal survival.
METHODS
This was a retrospective cohort study of monochorionic diamniotic twin pregnancies diagnosed with sFGR between 16 weeks' gestation and birth, conducted at the Fetal Medicine Unit at St George's Hospital, London, UK, a tertiary referral center for complicated multiple pregnancies. All cases, including external referrals, were identified through an electronic database search (Viewpoint 5.6.8.428, Wessling, Germany) of cases examined over a 15-year period, between March 2000 and May 2015. Pregnancies complicated by fetal abnormality, aneuploidy, genetic syndromes or those with missing pregnancy outcome data were excluded from the analysis.
Monochorionicity was determined on the first-trimester ultrasound scan in all cases based on a single placental mass with a T-sign and absent λ-sign 15 . Gestational age (GA) was determined according to the crown-rump length measurement of the larger twin on the first-trimester ultrasound assessment 16 . Pregnancies were dated according to head circumference measurement when the first ultrasound examination was performed after 14 weeks' gestation 17 . Pregnancies conceived by in-vitro fertilization were dated according to the embryonic age on the date of embryo transfer.
All cases underwent ultrasound assessment conducted by qualified and experienced operators using a 4-8-MHz convex probe on a Voluson GE ultrasound machine (GE Medical Systems, Zipf, Austria). Fetal biometry, Doppler assessment and evaluation of the DVP of the amniotic fluid were performed for each fetus during the ultrasound examination. The EFW for gestations < 20 and > 20 weeks was calculated using the formulae of Warsof et al. 18 and Hadlock et al. 19 , respectively. sFGR was diagnosed according to the guideline of the International Society of Ultrasound in Obstetrics and Gynecology when the EFW of one fetus was below the 10 th centile and the intertwin EFW discordance was greater than 25% 6 . Intertwin EFW discordance was calculated as 100× (A − B)/A, where A is the EFW of the larger fetus and B the EFW of the smaller one.
Doppler assessment of the UAs of both fetuses was conducted in all cases and the EDF of the smaller twin was classified as positive, absent or reversed. The UA Doppler waveform was produced by sampling free loops of the umbilical cord using color Doppler during a period of fetal quiescence. The UA Doppler pattern was classified as Type I when the EDF was persistently positive, Type II when the flow was persistently absent or reversed and Type III in cases in which the EDF was intermittently absent or reversed. Classification of the type of sFGR was assigned at initial presentation and all subsequent ultrasound assessments. Doppler evaluation of the fetal ductus venosus (DV) was performed on both fetuses and the a-wave was categorized as positive, negative or reversed 20 . The DV was identified as the vessel connecting the intra-abdominal portion of the umbilical vein with the inferior vena cava using color Doppler ultrasonography during a period of fetal quiescence. The pulsatility index for veins (PIV) of the DV was calculated according to the standard formula for each twin, and these values were converted to Z-scores to correct for GA 21 . Progression of Type-I sFGR was defined as the evolution of EDF present on UA Doppler to absent or reversed (Type II) or intermittent or cycling (Type III) flow during any subsequent ultrasound assessment. Progression of Type-II sFGR was defined if EDF was absent on UA Doppler at the time of diagnosis and proceeded to reversed or intermittent flow (Type III) on a subsequent ultrasound assessment. Pregnancies complicated by isolated Type-I sFGR were managed conservatively. Indications for proceeding with laser coagulation therapy in sFGR cases included progression to Type II at GA < 26 weeks for which the prognosis was particularly guarded, and the presence of coexisting TTTS, which was diagnosed and staged according to the Quintero classification system 11 . Pregnancies complicated by Stage-I TTTS were managed conservatively in keeping with existing evidence. Pregnancies complicated by or progressing to Stage-II TTTS were routinely offered fetoscopic laser intervention. This was performed in keeping with standard techniques described in the literature 22 . The option of cord occlusion or selective feticide in cases undergoing fetoscopic laser therapy for TTTS complicated by severe sFGR was discussed preoperatively. Amniodrainage was performed routinely at the end of fetoscopic surgery and in isolation as a therapeutic intervention in cases of atypical late-onset TTTS.
The indication for and mode of delivery were at the discretion of the attending physician. Maternal characteristics including age, ethnicity (Asian, black, Caucasian, mixed and other), body mass index and method of conception were recorded. Data on pregnancy outcome were collected from hospital obstetric and neonatal records. These included pregnancy outcome of both twins (live birth, stillbirth, neonatal death before or after 1 week from delivery and termination of pregnancy), GA at delivery, birth weight and admission to the neonatal intensive care unit. Perinatal mortality included stillbirth and neonatal death within the first 28 days following delivery. Stillbirth was defined as fetal demise after 24 completed weeks of pregnancy. EFW and birth-weight values were converted to centiles to correct for GA 23, 24 . Continuous variables are presented as median (interquartile range (IQR)), and categorical variables are presented as a fraction of the total with percentages. Distribution assumptions of variables were tested using the Shapiro-Wilk test. Comparisons of continuous variables between groups were performed using the t-test or Wilcoxon rank-sum test. Comparison of categorical variables was performed using Fisher's exact test. Cox proportional hazards models were used to assess the importance of antenatal and ultrasound variables on the survival time of the smaller twin. Statistical analysis was performed using RStudio statistical software (Version 1.0.136; RStudio, Inc.); P < 0.05 was considered to indicate statistical significance.
RESULTS
We identified 123 monochorionic diamniotic twin pregnancies that were diagnosed with sFGR during the study period. We excluded 16 (13.0%) pregnancies that were complicated by fetal structural abnormality or aneuploidy or were lost to follow-up; therefore, a final cohort of 107 pregnancies (214 fetuses) was available for analysis. Of these, 66 (61.7%) were diagnosed with Type-I, 38 (35.5%) with Type-II and three (2.8%) with Type-III sFGR at the initial presentation. Seventy-five (70.1%) pregnancies resulted in survival of both twins, which included the three cases of sFGR Type III. Twenty-three (21.5%) pregnancies were complicated by demise of either the smaller or larger twin, thus resulting in one survivor. Two-thirds of these cases of a single survivor involved the demise of the smaller twin. Nine (8.4%) pregnancies (three Type-I and six Type-II sFGR) were complicated by double perinatal demise. Given the small number of cases with Type-III sFGR, the analysis focused primarily on the 104 pregnancies complicated by Type-I or Type-II sFGR.
Antenatal and ultrasound variables and pregnancy outcome data for the twin pregnancies complicated by Type-I vs those with Type-II sFGR are presented in Table 1 . Throughout pregnancy, 13 (19.7%) cases of Type-I and 13 (34.2%) cases of Type-II sFGR progressed to a more advanced stage. Pregnancies complicated by Type-II sFGR at initial presentation were diagnosed significantly earlier (median GA, 19.6 (IQR, 17.3-23.9) weeks) than those with Type-I sFGR (median GA, 21.5 (IQR, 18.9-26.5) weeks) (P = 0.012). They were also delivered earlier, at a median GA of 30.4 (IQR, 28.0-34.0) weeks for Type II vs 32.6 (IQR, 30.7-34.8) weeks for Type I, with a trend toward statistical significance (P = 0.055). With regard to ultrasound variables, the smaller twin in pregnancies complicated by Type-II sFGR had significantly higher DV-PIV Z-score than did the smaller twin in pregnancies with Type-I sFGR (P < 0.001). Pregnancies complicated by Type-I sFGR had significantly lower rates of intrauterine demise (IUD) of the smaller twin (P = 0.004) and higher rates of survival of both fetuses (P = 0.002) compared with pregnancies with Type-II sFGR. Outcome data of pregnancies with Type-I and Type-II sFGR, excluding cases with TTTS (isolated sFGR), are provided in Table S1 .
Maternal and gestational characteristics of the pregnancies resulting in live birth vs those complicated by perinatal demise, and subgroup analysis for Type-I and Type-II sFGR are presented in Table S2 and Table 2 , respectively. Pregnancies diagnosed with Type-I sFGR resulting in perinatal demise were both diagnosed and delivered significantly earlier than those resulting in live birth ( Table 2 ). The median time between diagnosis and delivery was similar between the Type-I sFGR pregnancies that resulted in perinatal demise and those that did not (10.71 vs 9.57 weeks; P = 0.688), owing to earlier diagnosis and delivery time in the perinatal demise group. A comparison of ultrasound characteristics revealed that Type-I sFGR pregnancies complicated by perinatal demise, compared with those that were not, had higher DV-PIV Z-scores in the smaller (P = 0.206) and larger (P < 0.001) fetuses, albeit the difference for the smaller twins did not reach statistical significance. A significantly higher proportion of Type-I sFGR pregnancies resulting in perinatal demise underwent fetoscopic laser procedures (69.2% vs 15.1%; P < 0.001) and had significantly lower median birth-weight centile of the smaller fetus (0.00 (IQR, 0.00-0.16) vs 1.18 (IQR, 0.04-6.44); P = 0.005), in comparison with Type-I sFGR pregnancies that resulted in the live birth of both twins. Similar significant differences were observed in pregnancies diagnosed with Type-II sFGR between those complicated by perinatal demise and those that were not, including the earlier onset of diagnosis (P = 0.002), higher DV-PIV Z-score of the smaller twin (P = 0.003) and lower birth-weight centile of the smaller twin (P = 0.004) in the pregnancies with perinatal demise (Table 2) . Further analysis of sFGR pregnancies complicated by TTTS vs those that were not is illustrated in Table 3 . There was no significant impact of TTTS on the pregnancy outcomes of either Type-I or Type-II sFGR with coexisting TTTS (P > 0.05 for both).
Treatment modalities included 36 cases of laser coagulation therapy, one cord occlusion and three amniodrainage procedures. Of the 36 cases treated with endoscopic laser therapy, 28 had coexisting TTTS and eight had isolated sFGR. Perinatal outcome of the 36 cases treated with laser therapy included six double losses, 15 pregnancies resulting in one survivor and 15 cases of double live birth.
Cox proportional hazard regression models (Table 4 ) revealed that GA at diagnosis (hazard ratio (HR), 0.70 (95% CI, 0.56-0.88); P = 0.002), Type-II sFGR (HR, 3.53 (95% CI, 1.37-9.07); P = 0.008) and DV-PIV Z-score (HR, 1.36 (95% CI, 1.12-1.65); P = 0.001) were significantly associated with an increased risk of adverse perinatal outcome of the smaller twin in pregnancies complicated by sFGR. When considering only pregnancies complicated by Type-I sFGR, GA at diagnosis (HR, 0.48 (95% CI, 0.27-0.84); P = 0.010) remained a significant predictor. DV-PIV Z-score (HR, 1.24 (95% CI, 1.00-1.55); P = 0.043) was significantly associated with adverse outcome of the smaller fetus in pregnancies complicated by sFGR Type II. Data are presented as n, median (interquartile range) or n (%). IUD, intrauterine fetal demise; NICU, neonatal intensive care unit. 
DISCUSSION

Summary of findings
The findings of this study demonstrate that twin pregnancies complicated by Type-II sFGR are diagnosed significantly earlier and are associated with an increased risk of adverse perinatal outcome when compared with pregnancies complicated by Type-I sFGR. Pregnancies complicated by sFGR and perinatal demise have a significantly earlier diagnosis, earlier GA at delivery, higher DV-PIV Z-score and lower birth-weight centile of the smaller twin compared with sFGR pregnancies resulting in live birth. Coexisting TTTS had no significant impact on the perinatal outcome of Type-I or Type-II sFGR pregnancies. Earlier GA at diagnosis, Type-II sFGR and higher DV-PIV Z-score are significantly associated with increased risk of adverse perinatal outcome of the smaller twin.
Interpretation and comparison with existing literature
The increased risk of adverse perinatal outcome associated with Type-II sFGR compared with Type-I has been reported by several research groups 8, 9, 25 . In 2015, Peeva et al. 10 examined Type-II sFGR pregnancies with and those without coexisting TTTS treated with endoscopic placental laser coagulation. In keeping with the findings of our study, they determined that survival was not related to the presence or absence of coexisting TTTS 10 . However, in contrast to our study, only cases complicated by Type-II sFGR were included in theirs. That study also determined that significant predictors of survival included the DV Doppler findings in the small twin, GA at laser coagulation and cervical length. The results of our regression analysis are in keeping with these conclusions.
The overall rate of IUD in all sFGR Type-I and sFGR Type-II pregnancies included in our study was 24.0% (25/104), which seemed slightly higher than expected. In order to examine further this finding, we performed a comparison with IUD rates in sFGR pregnancies reported in the literature (Table S3) 7, [25] [26] [27] . To the best of our knowledge, our study appears to be the first to date to include cases of both sFGR Types I and II with coexisting TTTS. The higher rate of IUD (39.5%) among pregnancies complicated by Type-II sFGR may be a consequence of the large number of cases referred to the unit, as referred pregnancies tend to be more complicated cases, leading to bias towards poorer perinatal outcome in the results.
Clinical and research implications
Two of the main difficulties related to sFGR are its diagnosis and determining subsequent management. The diagnostic criteria used in the literature vary significantly between research groups, making it difficult to form firm conclusions. In an attempt to standardize the diagnostic features of sFGR in twin pregnancy, Khalil et al. 28 undertook a Delphi procedure to reach a consensus. Once the diagnosis has been made, there is a distinct lack of robust data on which to base counseling of patients with regard to the outcome of these pregnancies. The findings of our study confirm that GA at diagnosis, the type of sFGR and DV-PIV should be used in order to identify those pregnancies at increased risk of adverse outcome that may benefit from increased surveillance, and to initiate a discussion with regard to treatment options.
The optimal management of sFGR remains one of the key questions still to be addressed. For pregnancies complicated by sFGR with coexisting TTTS, laser coagulation therapy has been shown to be the optimal choice of treatment based on randomized controlled trials (RCTs). In cases of isolated sFGR, previous observational studies and the findings of our study suggest that Type-I sFGR pregnancies have a favorable outcome, therefore, the current practice of conservative management seems reasonable. In cases of expectant management, parents should be adequately counseled regarding the risk of IUD and its potential consequences for the cotwin. The appropriate timing of delivery of Type-I sFGR pregnancies remains to be determined.
Type-II sFGR pregnancies have a much poorer prognosis and are typically characterized by progressive deterioration. The evaluation of prognostic factors may assist in triaging these pregnancies to identify those at increased risk of demise that would possibly benefit from therapeutic intervention. As well as conservative management and early delivery, treatment modalities include placental laser coagulation, selective reduction via cord occlusion or termination of pregnancy. We performed laser treatment in eight cases of isolated sFGR. Owing to the small numbers involved, it is difficult to draw conclusions, however, the survival rate was much lower than in pregnancies complicated by coexisting TTTS. To guide future clinical practice, we advocate the promotion of prospective multicenter observational studies and the formation of a registry to delineate accurate criteria for predicting outcome in sFGR on which a subsequent RCT can be based.
Strengths and limitations
The main limitations of this study include the number of pregnancies involved in the analysis, as well as its retrospective design, and therefore the high risk of bias. To ensure adequate numbers for comparison, we performed the search of cases from a 15-year period. This may be a limitation, as clinical practice and protocols are subject to change over such a time period. An example of this is the small number of pregnancies diagnosed with Type-III sFGR. The main reason for this may be the lack of classification of sFGR prior to 2007 or the sampling methods used to interrogate the UA. The finding of significant relationships despite these numbers indicates the strength of the associations and their potential utility in a clinical setting. Cases that subsequently developed TTTS after an initial diagnosis of sFGR were included in order to give a true representation of the clinical outcomes associated with pregnancies complicated by sFGR. Our study, therefore, provides information for comprehensive counseling of all growth-restricted monochorionic twin pregnancies. When performing statistical analysis, we adjusted for confounding variables such as GA to ensure accurate analysis and interpretation of the data.
Conclusions
Pregnancies complicated by Type-II sFGR are diagnosed significantly earlier and are associated with increased risk of adverse perinatal outcome when compared with those with Type-I sFGR. Coexisting TTTS has no significant impact on the perinatal outcome of the twin pregnancies diagnosed with either Type-I or Type-II sFGR. Earlier GA at diagnosis, Type-II sFGR and higher DV-PIV Z-score are significantly and independently associated with increased risk of adverse perinatal outcome of the smaller twin.
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